Citigroup Issues Pessimistic Forecast for Integer (NYSE:ITGR) Stock Price

Key Points

• Citigroup cut its price target on Integer to $89 (from $92) and maintained a "neutral" rating, implying roughly a 6.4% upside from current levels.
• Shares fell about 5.5% to $83.62 after Q1 results that missed EPS by $0.01 ($1.20 vs. $1.21) despite a modest revenue beat, and FY2026 guidance of $5.83–$6.40 came in below consensus, pressuring sentiment.
• The board has launched a strategic review to maximize shareholder value; institutional investors own ~99.3% of the stock and insiders recently trimmed positions, highlighting active shareholder engagement and potential near-term volatility.

Integer (NYSE:ITGR - Get Free Report) had its target price decreased by research analysts at Citigroup from $92.00 to $89.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a "neutral" rating on the medical equipment provider's stock. Citigroup's target price would indicate a potential upside of 6.44% from the stock's current price.

Several other brokerages have also commented on ITGR. Piper Sandler reaffirmed an "overweight" rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a research note on Friday. Weiss Ratings raised Integer from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Tuesday, February 24th. Wall Street Zen lowered Integer from a "buy" rating to a "hold" rating in a research note on Sunday, January 25th. Raymond James Financial reissued an "outperform" rating and set a $101.00 target price on shares of Integer in a research note on Monday, February 23rd. Finally, Wells Fargo & Company increased their target price on Integer from $72.00 to $84.00 and gave the stock an "equal weight" rating in a research note on Friday, February 20th. Four analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $98.29.

Integer Trading Down 5.5%

Shares of Integer stock traded down $4.89 during trading hours on Friday, hitting $83.62. The company's stock had a trading volume of 602,713 shares, compared to its average volume of 740,517. Integer has a twelve month low of $62.00 and a twelve month high of $126.86. The firm has a fifty day moving average of $86.07 and a 200-day moving average of $81.76. The stock has a market cap of $2.85 billion, a price-to-earnings ratio of 29.04, a P/E/G ratio of 1.42 and a beta of 0.71. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.23 and a current ratio of 3.32.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 5.55% and a return on equity of 13.26%. The business had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. During the same period last year, the company earned $1.31 EPS. The business's revenue for the quarter was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Research analysts forecast that Integer will post 6.47 EPS for the current year.

Insider Transactions at Integer

In other Integer news, VP Tommy P. Thomas sold 825 shares of the stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the sale, the vice president owned 4,381 shares of the company's stock, valued at $372,385. This trade represents a 15.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.10% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Integer

A number of hedge funds have recently bought and sold shares of ITGR. Tudor Investment Corp ET AL raised its position in Integer by 50,787.5% in the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider's stock valued at $28,606,000 after purchasing an additional 29,442,029 shares in the last quarter. Irenic Capital Management LP acquired a new stake in Integer in the 4th quarter valued at about $99,109,000. Alliancebernstein L.P. raised its position in Integer by 885.1% in the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider's stock valued at $136,016,000 after purchasing an additional 993,810 shares in the last quarter. Millennium Management LLC raised its position in Integer by 3,350.2% in the 4th quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider's stock valued at $53,106,000 after purchasing an additional 657,483 shares in the last quarter. Finally, J. Goldman & Co LP purchased a new position in shares of Integer in the 4th quarter valued at about $40,531,000. Institutional investors and hedge funds own 99.29% of the company's stock.

Key Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Revenue and organic growth beat expectations — Q1 sales were roughly $440M (up 0.5% year-over-year) with 1.3% organic growth, driven by strength across key product lines. This topline beat is supporting optimism on demand recovery. ITGR Stock Up Despite Q1 Earnings Missing Estimates, Revenues Rise Y/Y
• Neutral Sentiment: Board has initiated a strategic review to “maximize stockholder value” (including possible sale, merger or other combinations). A review can unlock value but also creates execution and process uncertainty; outcomes are binary and timing is unclear. Integer Announces Strategic Review to Maximize Stockholder Value
• Neutral Sentiment: Company published the full Q1 release, slide deck and held its earnings call (transcript and presentation available). These materials provide detail on segment trends and margin drivers for investors doing deeper diligence. Integer Holdings Corporation 2026 Q1 - Results - Earnings Call Presentation
• Neutral Sentiment: Trading was temporarily halted pre-market on the day of the release for “news pending,” which typically increases short-term volume and volatility once resumed. Integer Announces Strategic Review to Maximize Stockholder Value
• Negative Sentiment: EPS missed consensus by a penny — reported $1.20 vs. $1.21 expected — and year-over-year EPS declined from $1.31, reflecting margin pressure that investors are watching closely. Integer (ITGR) Q1 Earnings Lag Estimates
• Negative Sentiment: FY 2026 EPS guidance was set to $5.83–$6.40, below the consensus (~$6.49), which raises investor concern about margin recovery and near-term earnings growth — a key reason for today’s downside pressure. Integer Q1 2026 Press Release / Guidance

About Integer

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.